scispace - formally typeset
T

Theresa Ben

Researcher at National Institutes of Health

Publications -  21
Citations -  1270

Theresa Ben is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Tissue transglutaminase & Phorbol. The author has an hindex of 16, co-authored 21 publications receiving 1268 citations.

Papers
More filters
Journal ArticleDOI

Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures

TL;DR: Evidence from the laboratory indicates that brief exposure to the potent phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA), stimulates DNA synthesis and ODC activity in mouse epidermal cell cultures.
Journal Article

Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.

TL;DR: Results indicate that heterogeneity exits within the epidermal cell population and that exposure to phorbol esters induces differentiation in some cells, while stimulating proliferation in others, and that such heterogeneous responses would cause a selective redistribution of theEpidermal Cell population and could lead to clonal expansion of initiated cells.
Journal ArticleDOI

Phorbol ester tumor promoters induce epidermal transglutaminase activity

TL;DR: Epidermal basal cells in culture have low levels of epidermal transglutaminase, the enzyme responsible for the formation of the cross-linked envelope in differentiated cells, but activity does not further increase when basal cells are treated with both retinoic acid and 12-O-tetradecanoylphorbol-13-acetate.
Journal Article

Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate.

TL;DR: This system appears to be a sensitive in vitro model for detecting the hyperplasia-inducing effects of phorbol esters and should be used for mechanistic studies and bioassay.
Journal ArticleDOI

Activation of viruses in human tumors by 5-iododeoxyuridine and dimethyl sulfoxide.

TL;DR: Dimethyl sulfoxide added to cultures first treated with 5-iododeoxyuridine increased C-type virus production approximately tenfold in a human rhabdomyosarcoma cell line.